NYSE American - Nasdaq Real Time Price USD
Oragenics, Inc. (OGEN)
0.1931
-0.0009
(-0.46%)
As of 1:30:09 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-8,597.3820
-8,597.3820
--
-15,228.4830
-13,470.2120
Investing Cash Flow
--
--
--
-115.5190
-43.8760
Financing Cash Flow
5,978.7210
5,978.7210
--
-494.9160
23,140.2160
End Cash Position
864.8400
864.8400
--
11,426.7850
27,265.7030
Interest Paid Supplemental Data
29.8280
29.8280
30.5910
9.2900
15.7560
Capital Expenditure
--
--
--
-127.5190
-43.8760
Issuance of Capital Stock
6,671.8300
6,671.8300
--
69.2890
26,676.3920
Repayment of Debt
-693.1090
-693.1090
--
-564.2050
-524.9800
Repurchase of Capital Stock
--
--
--
--
-5,635.6720
Free Cash Flow
-8,597.3820
-8,597.3820
--
-15,356.0020
-13,514.0880
12/31/2021 - 2/25/2004
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CDT Conduit Pharmaceuticals Inc.
0.5583
+0.32%
IGC IGC Pharma, Inc.
0.3062
+4.15%
VTVT vTv Therapeutics Inc.
21.04
+3.57%
ABVC ABVC BioPharma, Inc.
0.9200
+5.02%
MTNB Matinas BioPharma Holdings, Inc.
0.5940
+1.54%
JAGX Jaguar Health, Inc.
8.18
+23.01%
QNRX Quoin Pharmaceuticals, Ltd.
6.54
+3.15%
ONVO Organovo Holdings, Inc.
2.0400
+1.49%
TRAW Traws Pharma, Inc.
1.5300
+4.08%
INZY Inozyme Pharma, Inc.
0.9593
-2.17%